Summary
Tetrahydrobiopterin (BH4) deficiency is an autosomal recessive disorder caused by enzyme defects in the biosynthesis or recycling of BH4. Patients with BH4 deficiency present with severe neurological signs and symptoms and .require a different treatment from classical phenylketonuria. During the last 12 years, 31 cases of BH4 deficiency were identified in our department. They were all classified as 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency. They were diagnosed at the ages of 2.5–48 months and treated with BH4, L-dopa and 5-hydroxytryptophan immediately after diagnosis. The average development quotients (DQ) at diagnosis and after treatment for more than 3 years were 53± 16, and 78± 15, respectively. A significant negative correlation was observed between the level of the DQ and the age at which treatment was commenced (r = −0.751, p = 0.002). Developmental profiles were uneven. Language, adaptability and at later age mathematics were particularly weak areas. Only two patients achieved a good performance in mathematics. Eleven patients who were treated with drugs from ages of 2.9–48 months had neuroradiological scanning. Computed tomography disclosed calcification in lentiform nuclei in one patient and magnetic resonance imaging disclosed delayed myelination and abnormal high intensity signal in cerebral white matter in all of them. Even though most of abnormalities were reversible, small patchy or spotted areas were still present on these regions after treatment for 10–46 months. In summary, our study supports the substantial efficacy of the current therapeutic approach in PTPS deficiency of normalizing amine neurotransmitters with three drugs as early as possible. For the first time, calcifications could be detected in patients with PTPS deficiency. Abnormalities in white matter on magnetic resonance imaging were not related to clinical manifestations and most were reversible.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Blau N, Barnes I, Dhondt JL (1996a) International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis 19: 8–14.
Blau N, Kierat L, Heizmann CW, et al (1992) Screening for tetrahydrobiopterin deficiency in newborns using dried urine on filter paper. J Inherit Metab Dis 15: 402–404.
Blau N (1996b) The hyperphenyalaninemias: a differential diagnosis and international database of tetrahydrobiopterin deficiencies. Marburg: Tectum Verlag.
Brismar J, Aqeel A, Gascon G, et al (1990) Malignant hyperphenylalaninemia: CT and MR of the brain. AJNR Am J Neuroradiol 11(1): 135–138.
Chien Y-H, Chiang S-C, Huang A, et al (2001) Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase (PTPS) gene mutations. J Inherit Metab Dis 24: 815–823.
Chien Y-H, Pen S-F, Wang T-Rn, et al (2002) Cranial MR spectroscopy of tetrahydrobiopterin deficiency. Am J Neuroradiol 23: 1055–1058.
Curtius HC, Blau N, Kuster T (1991) Pterins. In: Hommes FA, ed. Techniques in Diagnostic Human Biochemical Genetics. A Laboratory Manual. New York: Wiley-Liss, 377–396.
Dhondt JL (1984) Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey. J Pediatr 104: 501–508.
Dhondt JL, Largilliere C, Ardouin P, et al (1981) Diagnosis of variants of hyperphenylalaninemia by determination of pterins in urine. Clin Chim Acta 110: 205–214.
Conoley JC, Impera JC (1995) Gesell Child Developmental Age Scale. The Twelfth Mental Measurements Yearbook.
Kaufman S (1993) New tetrahydrobiopterin-dependent systems. Annu Rev Nutr 13: 261–286.
Liu TT, Chiang SHI, Wu SJ, et al (2001a) Tetrahydrobiopterin-deficienct hyperphylalaninemia in the Chinese. Clin Chim Acta 313: 157–169.
Niederwieser A, Staudenmann W, Wetzel E (1984) High-performance liquid chromatography with column switching for the analysis of biogenic amine metabolites and pterins. J Chromatogr 290: 237–246.
Niederwieser A, Curtius HC, Viscontini M, et al (1979) Phenylketonuria variants. Lancet 1979;1:550.
Ponzole A, Guardamagna O, Spada M, et al (1993) Differential diagnosis of hyperphenylalaninaemia by a combined phenylalanine-tetrahydrobiopterin loading test. Eur J Pediatr 152: 655–661.
Thompson AJ, Smith T, Kendall BE, et al (1991) Magnetic resonance imaging changes in early treated patients with phenylketonuria. Lancet 377: 1224–1228.
Staudt M, Schropp C, Staudt F, et al (1994) MRI assessment of myelination: an age standardization. Pediatr Radiol 24: 122–127.
Wechsler D (1986) Wechsler Intelligence Scale for Children–Revised for China. Changsha, China: Human Medical University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Georg Hoffmann
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Wang, L., Yu, WM., He, C. et al. Long-term outcome and neuroradiological findings of 31 patients with 6-pyruvoyltetrahydropterin synthase deficiency. J Inherit Metab Dis 29, 127–134 (2006). https://doi.org/10.1007/s10545-006-0080-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0080-y